This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: Zenyaku Kogyo Kabushiki Kaisha. Active years: 2000-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2007
Title: Hiroya Sasahara: Innovator in Antitumor Compounds
Introduction
Hiroya Sasahara is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of heterocyclic compounds with antitumor properties. With a total of 4 patents to his name, his work has the potential to impact cancer treatment significantly.
Latest Patents
Sasahara's latest patents include innovative formulations of heterocyclic compounds. One notable patent is focused on a heterocyclic compound and an antitumor agent containing the same as an effective ingredient. This invention relates to compounds represented by a specific formula, where various substituents are defined to enhance their therapeutic efficacy. Another patent details heterocyclic compounds and antitumor drugs containing these compounds as active ingredients, showcasing his commitment to advancing cancer therapies.
Career Highlights
Hiroya Sasahara has built a successful career at Zenyaku Kogyo Kabushiki Kaisha, where he has been instrumental in research and development. His expertise in medicinal chemistry has led to the creation of several innovative compounds that hold promise for future medical applications. His work is characterized by a focus on the synthesis and application of heterocyclic compounds in pharmacology.
Collaborations
Throughout his career, Sasahara has collaborated with esteemed colleagues such as Seiichiro Kawashima and Toshiyuki Matsuno. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their research.
Conclusion
Hiroya Sasahara's contributions to the field of medicinal chemistry, particularly in the development of antitumor agents, highlight his role as a key innovator. His patents reflect a dedication to improving cancer treatment through innovative chemical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
